Schedule 13G ownership disclosure

ARROWHEAD PHARMACEUTICALS INC COM

Common Stock, par value $0.001 per share · CUSIP: 04280A100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avoro Capital Advisors LLC

    Shares: 12,028,552.00 · Class: 9.6%

  • Behzad Aghazadeh

    Shares: 12,028,552.00 · Class: 9.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-000986
Form type
SCHEDULE 13G/A
Filer
ARROWHEAD PHARMACEUTICALS, INC.
CIK
CIK 879407
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub